Pfizer, Starboard Value
(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...
Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.
Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...
2don MSN
Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder and CEO of activist ...
The activist investor claims Pfizer failed to capitalize on the windfall earned from its COVID-19 vaccine and, in the process, destroyed tens of billions of dollars in market value.
Corvex Management LP has taken a stake in Fortrea Holdings Inc., a clinical trials management company that was spun out of ...
Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.
Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...
Starboard has a $1 billion stake in Pfizer and an unknown but "sizable" stake in Kenvue, according to earlier media reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback